Navigation Links
Tengion Announces Pricing of $31.4 Million Private Placement
Date:3/1/2011

rities laws of any such jurisdiction.

The securities to be sold in the private placement have not been registered under the Securities Act of 1933, as amended, or state securities laws and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission or an applicable exemption from such registration requirements. Tengion has agreed to file a registration statement with the Securities and Exchange Commission covering the resale of the shares of common stock, including the shares of common stock issuable upon exercise of the warrants, sold in the private placement. Tengion has agreed to file the registration statement within 45 days of the closing of the private placement. If any shares are unable to be included on the initial registration statement, Tengion has agreed to file subsequent registration statements until all the shares have been registered, and the registration rights agreement imposes certain customary cash penalties on Tengion for its failure to satisfy specified filing and effectiveness time periods.

About Tengion

Tengion, a clinical-stage biotechnology company, has pioneered the Organ Regeneration Platform™ that enables the Company to create proprietary product candidates that are intended to harness the intrinsic regenerative pathways of the body to produce a range of native-like organs and tissues. Tengion's product candidates seek to eliminate the need to utilize other tissues of the body for a purpose to which they are poorly suited, procure donor organs or administer anti-rejection medications. An initial clinical trial is ongoing for the Company's lead product candidate, the Neo-Urinary Conduit™, an autologous implant that is intended to catalyze regeneration of native-like bladder tissue for bladder cancer patients requiring a urinary diversion following bladder removal. The Company's lead preclinical program is the Neo-Kidney Augment™, which is de
'/>"/>

SOURCE Tengion
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Tengion Addresses Recent Trading Activity in its Common Stock
2. Tengion to Present at the 13th Annual BIO CEO & Investor Conference and the Leerink Swann Hot Topics in Therapeutics Roundtable Conference
3. Tengion Presents New Large Animal Data Demonstrating Functional Kidney Regeneration at the American Society for Transplantation Annual Conference
4. Tengion Appoints Richard E. Kuntz, MD to its Board of Directors
5. Tengion Announces Webcast of Analyst and Investor Meeting on October 27, 2010
6. Tengion Appoints A. Brian Davis Chief Financial Officer
7. Tengion Presents New Data Supporting its Organ Regeneration Platform™ at 8th Annual Meeting of the International Society for Stem Cell Research
8. Tengion Presents New Data Supporting Key Urologic and Kidney Programs at 16th Annual Meeting of the International Society for Cellular Therapy
9. Tengion to Present at the Piper Jaffray 20th Annual Healthcare Conference
10. Tengion Announces Second Closing of Series C Financing
11. Tengion Featured as Model of Innovation and Success at 35th Anniversary Celebration of the National Venture Capital Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... OncLive® is pleased to announce that ... Strategic Alliance Partnership program. , By participating ... will have the opportunity to work with the ... research initiatives, community-directed cancer prevention programs, and other ... OncLive to educate their peers by providing insights ...
(Date:7/22/2014)... (PRWEB) July 23, 2014 The ... , The goal of the Symposium is ... spectrum of scientists working in the biomaterials field, ... that represent the most promising directions for ultimate ...     Provide faculty and government scientists with ...
(Date:7/22/2014)... in water with ultrasound and they,ll spin around their ... yet knows exactly. But researchers at the National Institute ... it,s fast. At up to 150,000 revolutions per minute, ... object submerged in liquid ever reported. , The discovery ... that they could be used not only for moving ...
(Date:7/22/2014)... 22, 2014 CTD Holdings, Inc. (OTCQB:CTDH), ... medical device, cosmetics, and other markets, announced today that ... group of qualified private investors led by Novit L.P., ... , The transaction involved the signing of a Securities ... of Common Stock at a price per share of ...
Breaking Biology Technology:OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 3The 2014 NJ Symposium on Biomaterials Science Earns Society for Biomaterials Endorsement 2NIST shows ultrasonically propelled nanorods spin dizzyingly fast 2CTD Holdings Closes $1.725 Million Private Placement 2CTD Holdings Closes $1.725 Million Private Placement 3
... March 12 Biotechnology Value Fund, L.P. ("BVF"), today announced ... Avigen, Inc. (Nasdaq: AVGN ) urging stockholders to ... them with BVF,s four new, stockholder-oriented, independent director nominees at ... 27, 2009. BVF, the beneficial owner of approximately 30% ...
... March 12 The Board of Directors of CV Therapeutics, ... careful consideration of Astellas Pharma Inc.,s $16.00 per share cash ... determined that Astellas, offer undervalues the Company and is not ... Board of Directors recommends that stockholders not tender any of ...
... in Biomarker Research, Leading to Faster Medical SolutionsWALTHAM, Mass., ... open innovation marketplace, and FasterCures ... that two InnoCentive Solvers have been awarded $5,000 each ... FasterCures posted to InnoCentive,s online network in September ...
Cached Biology Technology:Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value 2Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value 3Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value 4Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value 5Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value 6Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value 7Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value 8Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value 9CV Therapeutics' Board of Directors Rejects Astellas' Tender Offer 2CV Therapeutics' Board of Directors Rejects Astellas' Tender Offer 3FasterCures Rewards Two InnoCentive Solvers for Innovative Ideas to Accelerate Medical Research 2FasterCures Rewards Two InnoCentive Solvers for Innovative Ideas to Accelerate Medical Research 3FasterCures Rewards Two InnoCentive Solvers for Innovative Ideas to Accelerate Medical Research 4FasterCures Rewards Two InnoCentive Solvers for Innovative Ideas to Accelerate Medical Research 5
(Date:7/23/2014)... , , , , , , ... , , , , , ... proposing that changing how medical care is delivered could help prevent multiple chronic diseases and extend healthy lifespan. The idea, they argue, would be to target ... , , , , ... , , , , , ...
(Date:7/23/2014)... releases about 60 billion tons of carbon into the ... released by burning fossil fuels. This happens through a ... is balanced by carbon coming into the soil system ... as by the underground activities of plant roots. ... increase the rate of soil respiration. As a result, ...
(Date:7/23/2014)... , July 23, 2014 BioCatch, ... detection, announced today it has been named in Gartner,s ... Market Guide replaces Gartner,s well-known Magic Quadrant for Web ... BioCatch as one of several vendors to deliver passive ... will become a standard feature of at least 30% ...
Breaking Biology News(10 mins):Strategy proposed for preventing diseases of aging 2Strategy proposed for preventing diseases of aging 3Strategy proposed for preventing diseases of aging 4Strategy proposed for preventing diseases of aging 5Climate change and the soil 2BioCatch Featured in Gartner's 2014 Online Fraud Detection Market Guide 2BioCatch Featured in Gartner's 2014 Online Fraud Detection Market Guide 3
... Xie, a senior scientist at the Marshall Institute for Interdisciplinary ... National Institutes of Health to lead a project to develop ... injuries. The project will combine the expertise of two ... in bone growth and development, and his team at MIIR ...
... ancient ape species called Oreopithecus bambolii has been a ... across its swampy Mediterranean island or did it move through the ... by University of Texas at Austin anthropologists Gabrielle A. Russo and ... in fact, walk habitually on two legs. The findings ...
... treat cancer patients with drugs that kill only cancer cells ... topics in the premiere segment of the 2013 season of ... the world,s largest scientific society. The videos are available at ... Titled Prized Science: Peter Stang on Building Molecules ...
Cached Biology News:MIIR scientist awarded $293,000 NIH grant 2Extinct ancient ape did not walk like a human, study shows 2American Chemical Society launches 2013 edition of popular Prized Science video series 2
... Phosphothioate (PTO) oligonucleotides: PTOs are ... the phosphate backbone is replaced by a ... against nuclease degradation. PTOs are available as ... are phosphothioates Oligonucleotides with thio-caps ...
The mini vertical flow workbench is designed to perform PCR protocols in a particle-free environment. The built-in UV light ensures the elimination of any nucleic acid to avoid cross-contamination....
... For microsatellite research, the 4300 System ... genotyping automation software available. SagaGT automates electrophoresis, ... band sizes, and allele scoring. ,Saga GT ... LI-COR. Saga 1.0 (Unix) was initially developed ...
MOUSE ANTI GTP BINDING PROTEIN...
Biology Products: